Clinical trialPhase 4Completed
CTC Pancreatic Adenocarcinoma
Resectable Pancreatic Adenocarcinoma - Does the Type of Anesthesia Have an Impact on Circulating Tumor Cells?
- Outcome
- Finished, no results posted
- Phase
- Phase 4
- Status
- Completed
- Study type
- Interventional
- Start
- October 2016
- Ended
- October 2019
- Enrollment
- 86 participants
- Sites
- 4
- Primary outcomes
- Peak of CTC in the postoperative phase after curative tumor removal
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 13 December 2019
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Proportion of circulating tumor cells (CTC) in the postoperative phase after curative tumor removal of pancreatic cancer will be determined and correlated to the accordance of anesthesia (desflurane versus propofol)
Detailed description public domain (ClinicalTrials.gov)
This prospective, randomized study will be conducted over a 36-month period to investigate whether commonly used anesthetics (volatile versus intravenous) have an effect on the changes or occurrence of CTC in patients suffering from primary pancreatic cancer undergoing curative surgery. The specific research question is if there are changes of the CTC count in the postoperative phase in the desflurane group (intervention) compared to the propofol one (control). A secondary question is if these changes can be correlated to tumor outcome.